SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-056806
Filing Date
2023-07-13
Accepted
2023-07-13 17:00:16
Documents
12
Period of Report
2023-07-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181769-8k_oramedpharm.htm   iXBRL 8-K 44684
  Complete submission text file 0001213900-23-056806.txt   219323

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ormp-20230713.xsd EX-101.SCH 3007
3 XBRL LABEL FILE ormp-20230713_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ormp-20230713_pre.xml EX-101.PRE 22391
6 EXTRACTED XBRL INSTANCE DOCUMENT ea181769-8k_oramedpharm_htm.xml XML 3612
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 231087299
SIC: 2834 Pharmaceutical Preparations